SEC Form 4 · accession 0001104659-18-045783
Neon Therapeutics, Inc. · NTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yasir B. Al-Wakeel
Officer — Chief Financial Officer
Period of report
Jul 17, 2018
Accepted (ET)
Jul 18, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001694187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 17, 2018 | M | 17,241 | $5.80 | A | 17,241 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.80 | Jul 17, 2018 | M | 17,241 | D | — | — | Common Stock | 17,241 | 192,759 | D |
Explanation of responses
- F125% shares vested on July 5, 2018, with the remainder vesting over 12 equal quarterly installments thereafter.